Blog

Health Law News, Private Equity

Print PDF

Private Equity Deal Spotlight | Weekly Update

Posted on December 5, 2024 in Health Law News, Private Equity

Published by: Hall Render

Health care continues to drive private equity (“PE”) activity, creating opportunities for investors and traditional health care providers. Transactions in the health care space are especially complicated, layering health care regulatory and reimbursement considerations on top of a complex securities, antitrust, privacy and security framework.

Hall Render’s PE team of attorneys and advisors leverage the strength and depth of our bench to navigate and efficiently execute PE transactions. The summary below includes highlights of recent PE deals and legislative updates.

  • CVC Capital Partners completed an acquisition of Therakos, Inc. from Mallinckrodt Pharmaceuticals for a purchase price of $925 million. Therakos specializes in extracorporeal photopheresis delivery systems for use around the world, used to treat immune-related diseases. CVC aims to continue research and development while expanding Therakos’ geographical footprint. CVC is a global PE firm with $117 billion in assets under management.
  • Arlington Capital Partners announced the acquisition of TEAM Technologies, Inc., a provider of design, manufacturing and supply chain services to medical device and pharmaceutical original equipment manufacturers. Arlington Capital plans to build on TEAM Technologies’ strong foundation in supply chains, adding capabilities and growing the company’s customer base. Arlington Capital is a Washington, D.C.-based private investment firm specializing in the health care industry.
  • Astorg, a European-based PE firm, completed a take-private of Hamilton Thorne and the simultaneous acquisition of Cook Medical’s reproductive health business (Cook Medical RH). Cook Medical RH maintains a leading portfolio of assisted reproductive technology (ART) consumables and equipment, while Hamilton Thorne produces ART precision instruments, consumables, software and services. The combination of Hamilton Thorne and Cook Medical RH is intended to create a global leader in ART and in vitro fertilization products and services. Astorg plans to launch a new brand identity for the company in 2025.

If you have any questions or would like additional information, please contact:

Hall Render blog posts and articles are intended for informational purposes only. For ethical reasons, Hall Render attorneys cannot—outside of an attorney-client relationship—answer specific questions that would be legal advice.